Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based Founder operating in the Health Care space. If you think a Founder is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Yusuf Sherwani
Co-Founder & CEO of Quit Genius
Yusuf is the Co-Founder and CEO of Quit Genius. He is a Y Combinator alumni and was featured by Fast Company’s as one of their Most Creative People of 2019 as well as Forbes’ 30 Under 30 List of 2018.
Follow Yusuf Sherwani:
About Quit Genius: Quit Genius is pioneering digital therapeutics for multiple addictions.
_______
Andre Chow
Co-Founder & Co-CEO of Digital Surgery
Andre is a General Surgeon, Web coder, UX designer and all-round hacker. He has a BSc in Surgical Technology, a PhD in Tissue Engineering and leads Operations & Product. When not in the lab, Andre spends his spare time playing a variety of sports, and trying to push his french bulldog off the sofa.
Follow Andre Chow:
About Creative Destruction Lab (CDL), Digital Surgery, Medtronic, Touch Surgery: Digital Surgery is a privately-held pioneer in surgical artificial intelligence (AI), data and analytics, and digital education and training
Valentina Milanova
Founder and CEO of Daye
Valentina previously worked with Techstars as a Business Development Associate. She is currently looking after the AI portfolio at Founders Factory – launching 200 businesses in the next five years! Before entering the startup and VC worlds, Valentina studied law and worked as a technology correspondent for large international publications.
Follow Valentina Milanova:
About Daye: Daye creates category-defining products and services that set a new standard for medical research and scientific innovation.
Peter Roberts
Founder of Pure Gym
Peter is a serial entrepreneur with a distinguished career in the leisure industry. Earlier ventures include the formation of Langdale Group Plc which sold for £29m in 1989 to Scottish & Newcastle. He set up nightclub company Luminar, which completed a successful IPO in 1998, food/pub chain Countrystyle Inns which sold in 1995 for an IRR of 35% and a Venture Capital Fund with Lazard Ventures. In 2000 Peter founded Golden Tulip Hotels, a budget hotel group, sold to Whitbread in 2008. In 2015 Peter was named a winner in the EY Entrepreneur of the Year awards and overall winner for the North of England. Peter is now involved with helping young entrepreneurs to develop their businesses.
Follow Peter Roberts:
About Pure Gym: PureGym is a gym operator that provides affordable and convenient access to fitness facilities in the U.K.
James Wolffsohn
Founder of Aston EyeTech Ltd
James Wolffsohn is one of the leading UK academics in the ophthalmic research field with over two hundred research papers, 16 book Chapters and two books (including books on ophthalmic imaging) principally in the areas of contact lenses, intraocular lenses, accommodation and low vision. Having worked at the University for 15 years James is now the Deputy Executive Dean of Life and Health Sciences and has a wide range of responsibilities at the University both from a profession management and principal investigator perspective. James has over 200 abstracts published at conferences in Europe, USA, Asia and Australia. Over £4 million in research grants from grant awarding bodies and industry. James has had 17 PhD’s awarded to students and currently has 7 in progress and 15 post doctorial research fellows with 4 currently in progress. James started to move into ‘engineering’ based research in Life and Health Sciences in 2008 and has had significant success in the field, developing innovative products and securing IP with a range of research tools.
Follow James Wolffsohn:
About Aston EyeTech Ltd, Aston University, Aston University, University of Houston, Visioncare Research: Aston EyeTech is the commercialisation spin-out from Aston University, developing a range of products to support practising optometrists.
Mark Dunne
Founder of Aston EyeTech Ltd
Mark graduated from the University College of North Wales, Bangor in 1983 with a degree in Zoology. His postgraduate studies were carried out in the Department of Vision Sciences at Aston University. Here, he examined the relationship between ocular biometry, involving development of an ultrasonic ophthalmophakometric technique, and peripheral refraction under the supervision of Derek Barnes. His thesis entitled ‘An Optical Study of Human Ocular Dimensions’ led to the award of a PhD in 1987. During the last year of his postgraduate studies, he became a research assistant on a project, carried out at Aston and funded by the TRRL, looking into road direction sign optimisation. Mark then studied for a degree in Ophthalmic Optics (Optometry) for which he graduated with first class honours in 1989 and became a registered member of the College of Optometrists in 1990. He was appointed as a lecturer at Aston in 1990 and promoted to senior lecturer in 2007. Since then, he has continued his research interests in the fields of ocular biometry and the visual aspects of driving. He has been the optometry admissions tutor since 1996.
Follow Mark Dunne:
About Aston EyeTech Ltd, Aston University: Aston EyeTech is the commercialisation spin-out from Aston University, developing a range of products to support practising optometrists.
Julian Ranger
Chairman & Founder of Digime
After early work integrating as an aeronautical engineer, Julian founded STASYS Ltd in 1987, specialising in data interoperability and the military internet, and grew it to a staff of 230, with subsidiaries in the United States, Germany, Malaysia and Australia prior to its sale to Lockheed Martin in 2005. Julian’s management responsibilities encompassed the complete range from Board level vision, direction and control to business development, operational, finance and technical leadership, including developing the iSMART process used for interoperability management by militaries worldwide today. Julian left Lockheed in 2007 as Vice President International Strategic Development, and set up his angel investment and consultancy business, J Ranger Ltd. Julian has invested and supported over 20 start-up businesses, highlights include: Astrobotic, aiming to be the first commercial lunar landing, rover and exploration business; Hailo, revolutionizing the licenced taxi market worldwide; DataSift, providing intelligent access to the world’s social data streams. Julian continues to build new businesses, currently founder and Chairman of digi.me which is reimagining the personal internet putting users back in control of their own data. Julian is a Chartered Engineer, Fellow of the IMechE and Liveryman of the Worshipful Company of Engineers, and is also a Virgin Galactic Future Astronaut.
Follow Julian Ranger:
About Digime, iBundle, J Ranger, Kantara Initiative, Mobile Ecosystem Forum, Worshipful Company of Engineers: Digi.me allows consumers to gather their personal data and share it with businesses in a mutually beneficial value exchange.
Rudy Benfredj
Co-Founder & CEO of Mendelian
Follow Rudy Benfredj:
About Mendelian: Mendelian is helping doctors diagnose rare genetic diseases faster.
Fran Garcia
Co-Founder of Mendelian
Follow Fran Garcia:
About Mendelian: Mendelian is helping doctors diagnose rare genetic diseases faster.
Furquan Kidwai
Founder & CEO of Dawaai
Furquan Kidwai is an entrepreneur building a pharmacy for emerging Asia. Prior to this journey, Kidwai was an investment banker for over eight years in London where, in his last role, he was the Head of CEEMEA Financing as well as a Senior Vice President in the Fixed Income business at the Royal Bank of Scotland. Before joining RBS, Mr. Kidwai worked at Merrill Lynch and Lehman Brothers in their London and New York offices. Mr. Kidwai has a Master’s degree in International Relations from Cambridge University. He also holds an MSc in Financial Engineering & Risk Management from Imperial College London and BEng (Hons) in Electrical and Computer Engineering from the University of Bristol.
Follow Furquan Kidwai:
About Dawaai: Dawaai operates as a digital health platform with an online network of pharmacies and generic medicine.
Riya Grover
Co-Founder and CEO of Feedr
Riya Grover is the founder and CEO of Feedr, a scalable technology platform empowering healthy and artisan food vendors to produce and supply meals for the workplace.
Follow Riya Grover:
About Feedr: Feedr is an enterprise food technology platform that gives corporate customers software to support healthier daily eating in workplaces
Elizabeth Swanton
Co-Founder and COO of Feedr
Elizabeth Swanton is the founder and COO of Feedr, a scalable technology platform empowering healthy and artisan food vendors to produce and supply meals for the workplace.
Follow Elizabeth Swanton:
About Feedr: Feedr is an enterprise food technology platform that gives corporate customers software to support healthier daily eating in workplaces
Alon Laniado
Founder & CEO of FITMATE Coach
Alon Laniado is a Founder and CEO at Fitmate and the Founder and Chairman of Eternity Capital & Ventures. Prior to that, he was the Co-Founder of PathMotion (sold to PageUp).
Follow Alon Laniado:
About FITMATE Coach: Online personal 1:1 health coaching
Peter Hames
Co-Founder & CEO of Big Health
Peter Hames is CEO of Big Health, a digital medicine company he co-founded with clinical psychologist Prof Colin Espie (University of Oxford). Big Health creates automated behavioral medicine programs fuelled by tracked data, and was inspired by Peter’s difficulty in getting access to evidence-based non-drug solutions to his own insomnia. Big Health’s first product, Sleepio, is a digital sleep improvement program featuring personalized Cognitive Behavioral Therapy (CBT) techniques, delivered by virtual animated sleep expert The Prof and his narcoleptic dog Pavlov. In the world’s first placebo-controlled randomised trial for an intervention of its kind, Sleepio was shown to be comparable in effectiveness to face-to-face therapy.
Follow Peter Hames:
About Big Health, Lucky Voice, NHS England, Sleepio: Big Health is a digital therapeutics company operating a healthcare portal to offer behavioral programs for mental health issues.
Colin Espie
Co-Founder & Chief Medical Officer of Big Health
Colin Espie is Founder at Big Health.
Follow Colin Espie:
About Big Health, Sleepio, University of Glasgow, University of Oxford: Big Health is a digital therapeutics company operating a healthcare portal to offer behavioral programs for mental health issues.
Daniel Murray
Co-Founder of Heights
Dan is Co Founder at Grabble & Mobula, a serial entrepreneur, angel investor, & the UK Young Entrepreneur of the Year 2015 as well as being part of the Drapers 30 under 30 for fashion and on the advisory board of Retail Week Live. He runs an international community of entrepreneurs called Foundrs comprising 250 founders between London, LA and San Francisco. He also started Funconference, a 65 person weekend away for founders and CEOs where all content is curated and attended by fellow participants. He is also about to launch a podcast called “The Secret Lives of Leaders” in which he interviews the key people in the UK entrepreneurship sector, featuring founders of Just Eat, Photobox, Moonpig, Made.com, BBH, & even HRH Prince Andrew. The mobile commerce enthusiast is a keen public speaker on all things mobile and fashion, tweets @murraymuzz and writes a popular blog (www.startupmumblr.tumblr.com) about the lessons he learns growing a team and daily struggles of running a consumer start-up.
Follow Daniel Murray:
About Heights, Heights: Heights provide the daily nutrients, knowledge, and network you need to elevate your cognitive potential and brain health.
Joel Freeman
Co-Founder of Heights
Joel Freeman is the Co-Founder at Heights.
Follow Joel Freeman:
About Heights: Heights provide the daily nutrients, knowledge, and network you need to elevate your cognitive potential and brain health.
Michael Anstey
Co-Founder and Chief Operating Officer of Proteorex Therapeutics Inc.
Michael Anstey is an Investment Director specialising in healthcare investments. Before joining CIC he was a Principal in the Healthcare Practice Area at The Boston Consulting Group’s (BCG) Toronto office. Michael has experience in advising multinational healthcare businesses across North America, Europe, India, and Japan on a broad range of topics, including corporate strategy, sales and marketing, new launches, R&D and medical strategy, and M&A. Michael was co-founder and COO of an early stage biotechnology company focused on developing small molecule drugs that target protein-protein interactions implicated in disease. Prior to BCG, Michael worked in venture capital, where he focused on investing in early stage healthcare and life science businesses. Michael earned his DPhil in Zoology in the field of neurobiology, jointly supervised by professors at the University of Cambridge and the University of Oxford. Michael sits on the board of Bicycle Therapeutics.
Follow Michael Anstey:
About Cambridge Innovation Capital, Proteorex Therapeutics Inc.: Expanding horizons to find cures
Mayank Banerjee
Co-Founder and CEO of Even
Mayank Banerjee joined Even Healthcare as Co-Founder in 2020.
Follow Mayank Banerjee:
About Even: Even is a health-tech company and healthcare provider that partners directly with the top hospitals in the country.
George Goldsmith
Executive Chairman, Chief Executive Officer & Co-Founder of COMPASS Pathways
George is a serial entrepreneur with significant experience in pharmaceutical regulation. George’s early training and experience was a multi-disciplinary blending of cognitive psychology, clinical psychology and computer science.His first company, The Human Interface Group, was a pioneer in collaborative software and acquired by Lotus Development. George led the Lotus Institute and developed software and services to support high-performance, distributed teamwork. George then created TomorrowLab, which provided strategic guidance to internet businesses in the late 1990s. At the same time, he became a senior advisor to McKinsey & Company’s leadership, and eventually joined McKinsey as CEO of TomorrowLab@McKinsey. Subsequently, as a member of the Young Presidents Organisation (YPO) and its International Board of Directors, George founded YPO Networks. In 2002, George founded Tapestry Networks, an organisation committed to improving leadership performance and governance effectiveness in regulated sectors. He still serves as Tapestry Networks’ Non-Executive Chairman. George also serves on the board of directors for AnaBios, a company redefining drug discovery. He and his wife, Ekaterina Malievskaia MD, live in London.
Follow George Goldsmith:
About COMPASS Pathways: Compass Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health.
Ekaterina Malievskaia
Chief Innovation Officer & Co-Founder of COMPASS Pathways
Ekaterina received her medical degree from St Petersburg Medical Academy in St Petersburg, Russia. After her Internal Medicine residency training, she completed an Environmental Medicine Fellowship at Mount Sinai School of Medicine and received her MSc in Public Health from New York University Medical School. She worked in private practice, academic medicine and public health for more than 15 years in the greater New York area. She was a Clinical Instructor of Medicine at Mount Sinai School of Medicine, as well as a Research Professor at City University of New York. After moving to London in 2011, Ekaterina worked in global health and medical philanthropy, focusing on improving outcomes in maternal and child health. She founded COMPASS Pathways with her husband George Goldsmith in 2016, having experienced at first hand the challenges in accessing evidence-based and effective mental health care for a family member.
Follow Ekaterina Malievskaia:
About COMPASS Pathways: Compass Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health.
Matthew Goodman
Founder & Chief Medical Officer of Mapmyhealth
Matthew Goodman Chief Medical Officer Matthew studied medicine in the UK, qualifying as a doctor and becoming a general surgeon before specialising in endocrinology and pharmaceutical medicine. He began his career in industry by joining Sanofi, soon moving to Global positions with Novartis in both Switzerland and the US. In 2009 he returned to the UK to lead the Clinical Research programs of Prosidion, an Oxford-based biotechnology company breaking new ground in the treatment of diabetes and obesity. During his time as a research physician, along with his team, he was credited with the successful development of several cardiovascular and diabetes medicines today being used to successfully treat millions of patients worldwide. In 2012, Matthew founded Mapmyhealth, a company dedicated to the use of innovative technologies in the treatment of long-term conditions, from diabetes to cancer. Mapmyhealth now deliver their digital therapeutics to thousands of patients across the NHS and beyond, helping to advance care, improve disease management, prevent complications and reduce patient distress.
Follow Matthew Goodman:
About Mapmyhealth: Mapmyhealth design and develop technology enabled care services.
John M. Foraker
Co- Founder & CEO of Once Upon a Farm
John Foraker is the Co- Founder & CEO at Once Upon a Farm .
Follow John M. Foraker:
About Once Upon a Farm: Once Upon a Farm creates quality, eco-friendly, and nutritious food products for children.
George Pallis
Co-Founder & CEO of Manual
George Pallis is the Co-Founder and Chief Executive Officer of Manual.
Follow George Pallis:
About Manual: Manual provides diagnostic tools and testing to help patients make health-related decisions.
Michalis Gkontas
Co-Founder of Manual
Michalis Gkontas is the Co-Founder and Advisor of Manual.
Follow Michalis Gkontas:
About Manual: Manual provides diagnostic tools and testing to help patients make health-related decisions.
Peter Ward
CEO and Co-Founder of Humanity
Peter Ward is a Co-Founder and Chief Executive Officer at Humanity.
Follow Peter Ward:
About Humanity: Humanity is a healthcare company that aims to extend the healthspan of humanity.
Luke Heron
Co-Founder of TestCard Ltd
Luke Heron co-founded TestCard.com, a UK domiciled startup revolutionising the direct to consumer healthcare diagnostics market.
Follow Luke Heron:
About TestCard Ltd: TestCard is the medical technology company behind the eponymous at-home test kit. A partnering mobile app delivers immediate results.
Dr Andrew Botham
Co-Founder and CSO of TestCard Ltd
Follow Dr Andrew Botham:
About TestCard Ltd: TestCard is the medical technology company behind the eponymous at-home test kit. A partnering mobile app delivers immediate results.
Frank Hester OBE
Founder & CEO of The Phoenix Partnership
Frank has always been at the forefront of IT innovation. In his early career he was instrumental in building technological infrastructure in the finance industry. Frank founded TPP in 1997 and pioneered integrated care – delivering his vision of connected care across all health settings. Today, TPP provides leading software that is transforming healthcare worldwide. Frank is active in all aspects of the company’s business operations, working alongside the teams in the development of TPP’s products and representing the company in the public domain. Frank’s innovative vision is nationally recognised by the NHS, leading journals and healthcare organisations. In 2012, he was elected to the board of TechUK as a spokesperson for the healthcare IT sector. The following year, he was listed as one of the UK’s top 50 innovators in the national health publication, HSJ. In 2015, Frank was named on the Queen’s New Year’s Honours List to be awarded with an OBE (Order of the British Empire), for his services to healthcare. Frank has been invited on numerous government trade missions, representing the UK health industry around the world. He has visited countries such as China, India and Brazil as part of trade missions led by British Prime Minister, David Cameron and by Kenneth Clarke, QC, MP.
Follow Frank Hester OBE:
About The Phoenix Partnership: TPP is a healthcare technology company, dedicated to delivering world class healthcare software in the UK and internationally.
Abeed Mohamed
Co-Founder & CRO of Birdie
Abeed Mohamed is the Co-Founder and Chief Financial Officer of Birdie.
Follow Abeed Mohamed:
About Birdie: Birdie is a digital caretech company focused on elderly care at home.
Max Parmentier
Co-Founder & CEO of Birdie
Max Parmentier is the Co-Founder and Chief Executive Officer of Birdie.
Follow Max Parmentier:
About Birdie: Birdie is a digital caretech company focused on elderly care at home.
Gwen Le Calvez
Co-Founder & CTO of Birdie
Gwen Le Calvez is the Chief Technology Officer and Co-Founder of Birdie.
Follow Gwen Le Calvez:
About Birdie: Birdie is a digital caretech company focused on elderly care at home.
Rajiv Tanna
CPO & Co-Founder of Birdie
Rajiv Tanna is the Co-Founder and CPO of Birdie.
Follow Rajiv Tanna:
About Birdie: Birdie is a digital caretech company focused on elderly care at home.
Matt McCambridge
Co-Founder and CEO of Eden Health
Matt McCambridge is the Co-Founder and CEO at Eden Health.
Follow Matt McCambridge:
About Eden Health: Eden Health is a primary care and insurance navigation company for employers seeking to elevate the health and wellbeing of their employees.
Houman Ashrafian
Managing Partner & Founder of SV Health Investors
Houman Ashrafian is the Managing Partner at SV Health Investors.
Follow Houman Ashrafian:
About Catamaran Bio, Cellinta, Enara Bio, Karus Therapeutics, Sitryx Therapeutics, SV Health Investors, Zarodex Therapeutics: SV Health Investors is a Boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
Martin Blinder
Founder and CEO of Tictrac
Martin is an Internet and Digital Health entrepreneur with a focus on consumer web. He is co-founder and CEO of Tictrac, a leading Connected Health platform that engages people in their health, through their data. Tictrac is at the forefront of the consumerization of healthcare, centralizing an otherwise fragmented sector around the consumer, under the credo: consumer engagement is the key to better health outcomes. Tictrac won Best New Company at Health 2.0 in 2012. Martin was named among the 15 most influential in Digital Health, and has been featured in Wired, NYT, BBC, CNBC, Fortune, Mashable, Wall Street Journal, among others. He is also an active member of YPO, London chapter. Prior to Tictrac, Martin cofounded one of the first online financial services sites in Europe and has advised Prime Ministers and other state officials on innovation, foreign direct investment and entrepreneurship.
Follow Martin Blinder:
About Tictrac: Tictrac is a connected health platform that engages people in their health through their data.
Oliver MacCarthy
Founder and Chief Creative Technologist of Tictrac
Oliver MacCarthy is the Founder and Chief Creative Technologist at Tictrac
Follow Oliver MacCarthy:
About Tictrac: Tictrac is a connected health platform that engages people in their health through their data.
Stephan Tual
Founder, CEO of 3 Billion Pairs Genetic
Stephan Tual is the Founder & CEO at 3 Billion Pairs Genetics Ltd. & he attended Institut Franco-Américain de Management in 1995.
Follow Stephan Tual:
About 3 Billion Pairs Genetic: 3 Billion Pairs Genetic is a biotechnology based company.
Connor Campbell
Founder and CEO of Osler Diagnostics
Follow Connor Campbell:
About Osler Diagnostics: Lab-quality diagnostics for anyone, anywhere, at any time.
Paulo R. Bueno
Co-Founder of Osler Diagnostics
Paulo R. Bueno is the coordinator of the Nanobionics research group (www.nanobionics.pro.br) at São Paulo State University, UNESP. He published over 180 papers related to fundaments and applications of electric and electrochemistry time-dependent (including gravimetric and optical impedance) spectroscopic methods (h index 42, > 6500 citations with an average citation of higher than 25 per article, Google Scholar). His main scientific interest is focused on the fundaments and technological applications associated with electron charge transfer, transport and storage occurring at molecular and nanoscale structures. Under his guidance Nanobionics group develops synthetic structures and surfaces that mimic molecular and biological structures aiming applications in highly-relevant diagnostic devices. The Nanobionics group developed a totally new label-free diagnostic assay based on an electroanalytical spectroscopic methodology supported on the use of the electrochemistry capacitance, i.e. a capacitance proportional to the electrochemical density of states that intrinsically exists in mesoscopic structures comprised of redox-active molecules when attached over an electrode. These impedance-derived assays are able to detect target protein at femtomolar levels allowing the early detection of clinically relevant targets that are better than those currently commercial. They are potentially cheap and can be multiplexed. Other relevant aspects of his groups’ activities are the synthesis of self-assembled redox-tagged peptides and its applications in redox capacitive biosensors. The advantages of constructing a peptide-based receptive surface containing electrochemical tags are that peptides can be easily manipulated and optimized for applications containing complex biological environments. This tailoring ability avoids fouling and concomitantly can substitute antibodies by peptide or DNA aptamers as receptors with equivalent or superior affinity as well as specificity. Since 2008 Professor Bueno is engaged with tech transfer initiatives involving public-private start-up tech transfer projects with Scientific and Technological Parks in Sao Paulo. Because of such initiatives, Professor Bueno was invited to a plenary conference in the USA – Washington in 2009 by the US National Council of Entrepreneurial Tech Transfer in which Brazilian Tech Transfer context was introduced and discussed with the US and European Tech Transfer related agents and agencies. He is also engaged with UNESP internationalization program. Finally, he acted as academic and researcher visitor several times in European universities such as Universities of Valence and Jaume I (Spain), University of Paris (France) and University of Oxford. His collaborative work has been the subject of two significant awards from The Royal Society in the UK (a Brian Mercer Award in 2013 and a Newton Fellowship in 2015). His is currently administrating a Fellowship of Royal Society (Research Fellows Director, https://royalsociety.org/people/paulo-roberto-bueno-12682/). He is Fellows of Royal Society of Chemistry (FRSC) in the UK and member of American Chemical Society (ACS) in the USA. Also, he is a member of The Electrochemical Society (ECS) and International Society of Electrochemistry (ISE). Professor Bueno is the co-founder of Osler Diagnostics (http://oslerdiagnostics.com/), a start-up company from the University of Oxford.
Follow Paulo R. Bueno:
About Osler Diagnostics: Lab-quality diagnostics for anyone, anywhere, at any time.
Gregg Sando
Founder & former Chief Executive Officer of Kuur Therapeutics
Gregg Sando is the founder and CEO of Cell Medica. After a career in investment banking based both in London and New York, he completed his Immunology MSc degree at the medical school of Imperial College. Recognizing the significant progress taking place in the field of cellular immunotherapy, Gregg formed Cell Medica in cooperation with a small group of the leading clinicians and immunologists who were pioneering this new mode of medical treatment. (B.A. Biochemistry, Harvard University; M.B.A. University of Chicago; MSc Immunology, Imperial College London).
Follow Gregg Sando:
About Kuur Therapeutics: Kuur Therapeutics is committed to transforming the lives of patients with cancer & is leading the development cell therapies.
Rafael López Schietekat
Founder & Managing Director of Diagnostikare
Follow Rafael López Schietekat:
About Diagnostikare: The first data-driven patient-centric virtual primary care platform in Mexico.
Stewart Whiting
Tech Co-Founder & CTO of Current Health
Follow Stewart Whiting:
About Current Health: We help healthcare reduce risk & cost by monitoring, managing and engaging patients at home.
Matteo Berlucchi
CEO & Co-Founder of Healthily by Your.MD
Matteo’s digital career spans 20 years, during which he has conceived, built and launched several successful companies and services both online and on mobile. Most recently, Matteo was Chief Digital Officer at Northern & Shell, the largest independent media company in the UK,where he grew traffic and revenues 4-fold in just 12 months. Matteo was also the founder and CEO of aNobii, the ebook platform funded by Penguin Random House, HarperCollins which was acquired by Sainsbury’s in 2012. Matteo founded Livestation, the leading service for live TV news online and the first company in the world to stream live TV on iPhones. Livestation is also the winner of the Guardian Digital Innovation Award 2008. Prior to this, Matteo was CEO and co-founder of Skinkers, a software company, which defined the market for desktop widgets and the winner of several international innovation awards in the digital space. Matteo started his career by launching the first online property system in Europe in 1995.
Follow Matteo Berlucchi:
About Healthily by Your.MD, Vini Italiani: Healthily is the world’s first medically approved self-care app designed around you.
Tom Simmons
Founder & CEO of Supplant
Tom has over 10 years of experience in carbohydrate biochemistry. He formerly held fellowships at the University of Cambridge and at the World Economic Forum and has advocated sugar reduction initiatives through Sky News and Channel 4 television appearances.
Follow Tom Simmons:
About Cambridge Judge Business School, Supplant: Supplant is a biotechnology platform that makes sugar substitutes.
David Plans
CEO and Co-Founder of BioBeats
David Plans is a member of the University of Surrey’s Center for Digital Economy and Center for Vision, Speech and Signal Processing, and is working towards machine learning solutions to foster human wellbeing. His primary research focus is adaptive media and affective modelling. Having worked on early mHealth projects in the NHS, he is now leading smartphone and wearable research projects at BUPA, AXA/PPP, and Microsoft Health with his startup, BioBeats, where they are helping actuarial and care provision teams think differently about preventative health.
Follow David Plans:
About BioBeats: BioBeats is a human company that creates digital artificial intelligence products to tackle mental health globally.
Emil Hewage
Co-Founder & CEO of BIOS
Emil’s academic background is as a PhD researcher in computational neuroscience and machine learning. He brings knowledge of neural signalling and signal processing with over 7 year’s industrial & academic R&D experience. He has previously developed medical devices with Siemens Healthcare and Sphere Medical as well as having held roles in finance and medical and cleantech startups.
Follow Emil Hewage:
About BIOS: A full-stack neural interface platform, that uses AI to decode and encode the signals from to the body, to treat chronic health conditions.
Oliver Armitage
Co-Founder & CSO of BIOS
Oliver Armitage is Co-Founder and Chief Scientific Officer at BIOS, a leading neural engineering startup. Oliver has always had a vision that the human body could be repaired or made better through augmentative technology and how that can be used to improve people’s lives. He studied for his PhD at the University of Cambridge in Bioengineering, working in the world-renowned Nanoscience Centre. He specializes in tissue interfaces and engineering to allow technology to be fused with the body. Oliver was recently named to Forbes 30 Under 30 2018.
Follow Oliver Armitage:
About BIOS: A full-stack neural interface platform, that uses AI to decode and encode the signals from to the body, to treat chronic health conditions.
Sandeep Bansal
Founder & CEO of Medic Creations
Dr Bansal graduated from Imperial College London with a MSc in Paediatrics and Child Health. In 2013 he started his General Practitioner training at Oxford Deanery where he was also Trainee Lead, representing Oxford Deanery for the Associates in Training (AiT) committee in their quarterly meetings at Royal College of General Practitioners. From his professional experience and feedback from his peers, DrBansal raised the concerns of poor Information Governance (IG) compliance around sharing patient dataat AiT meetings. With the AiT board’s response of their inability to offer an alternative solution, Dr Bansalcarried out a survey to understand the extent of the problem in 2014. The survey for his 180 colleagues went viral and he received 2050 responses confirming the poor IG compliance practice, predominantly around the use of WhatsApp. In 2014 he set up Medic Creations and created the innovative app MedicBleep to enable secure and reliable clinical communication for primary, secondary and community care. With enabling communication across healthcare organisations and professionals, Medic Bleep empowerstrue interoperability, the future of healthcare management and innovation. Medic Creations was selected for Web Summit Alpha 2015 and is listed in the Journal of mHealth’s top100 Global Digital Companies for 2016 and 2017.
Follow Sandeep Bansal:
About Bennett Coleman and Co Ltd, Harvard Medical School, Medic Creations, shl.vc: Revolutionising Communications in Healthcare
Mark Kotter
Founder/CEO of bit.bio
Mark Kotter is the founder and CEO of bit.bio.
Follow Mark Kotter:
About bit.bio: Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.
Bunny Ghatrora
Co-Founder of Blume
Follow Bunny Ghatrora:
About Blume: Blume is the first direct to consumer brand focused on puberty, from trustworthy education, to safe & effective self care products.
Aris Papageorghiou
Co-Founder & CMO of Intelligent Ultrasound
Aris Papageorghiou is the Professor of Fetal Medicine at University of Oxford.
Follow Aris Papageorghiou:
About Intelligent Ultrasound, Royal College of Obstetricians and Gynaecologists, St Georges University Hospitals NHS Foundation Trust, Ultrasound Diagnostic Services, University of Oxford: Intelligent Ultrasound develops software that improves the quality, reliability, and diagnostic power of medical ultrasound.
Andrew Barker
Co-Founder & Director of Intelligent Ultrasound
Andrew Barker is the Chairman at Oxford Brain Diagnostics .
Follow Andrew Barker:
About Anchard Associates, Brainomix, Intelligent Ultrasound, Oxford Brain Diagnostics: Intelligent Ultrasound develops software that improves the quality, reliability, and diagnostic power of medical ultrasound.
Nader Alaghband
Co-Founder & CEO of Ampersand Health
Follow Nader Alaghband:
About Ampersand Health: Ampersand creates innovative digital medicines for complex long term conditions, using behavioural and data-science.
Amit Nathwani
Founder & Chief Scientific Officer of Freeline
Amit is renowned for his pioneering work on gene therapy for haemophilia B, and was first to show successful correction of bleeding diathesis in patients with severe haemophilia B. Amit is the Director of the Katharine Dormandy Haemophilia Centre at the Royal Free Hospital, and a Senior NIHR Investigator. He is also Professor of Haematology at UCL. He graduated in Medicine from the University of Aberdeen in 1984. In 1997 he moved to St. Jude Children’s Research Hospital, Memphis, USA, to work with Dr Arthur Nienhuis on adeno-associated virus mediated gene transfer. Here he started his pioneering work on gene therapy for haemophilia B. In 2001 he returned to University College London as a Senior Lecturer in Haematology and a Consultant to the National Blood Services in the UK. He was the first to show successful correction of bleeding diathesis in patients with severe haemophilia B, using a distinct gene transfer approach developed in collaboration with Dr’s Davidoff and Nienhuis at St Jude Children’s Research Hospital.
Follow Amit Nathwani:
About Freeline: Freeline Therapeutics is a biotechnology company focused on developing liver directed gene therapies for a range of diseases.
Jonathan Relph
Founder & CEO of VITL
Follow Jonathan Relph:
About VITL: On a mission to make healthy living more achievable, providing beautifully designed, expertly researched nutritional products and content.
Sameer Baroova
Co Founder & Chief Product Officer of FitXR
A lifelong fan of emerging technologies, Sameer found his flow in the video game industry working on mobile games from their onset, including titles such as Plants vs. Zombies and Bejewelled. Now Sameer uses his design, development, and management skills while building the best workout product on the market. At FitXR, Sameer loves combining immersive technology and AI to create unique personalised experiences that put the fun into fitness.
Follow Sameer Baroova:
About FitXR: FitXR, the leading developer of VR/AR fitness apps, is passionately dedicated to making fitness more fun and accessible for everyone.
Sam Cole
Co-Founder and CEO of FitXR
Sam draws on his experience from consulting and private equity to drive FitXR forward into the uncharted lands of fit tech. Coming from a family of entrepreneurs, Sam was always enchanted by the prospect of building a company. Meeting Sameer at business school kick-started that dream. A lover of all things fitness, Sam is excited to develop a product that will help people access professional workouts, and build healthier communities around the world.
Follow Sam Cole:
About FitXR: FitXR, the leading developer of VR/AR fitness apps, is passionately dedicated to making fitness more fun and accessible for everyone.
Mohammed Tayeb
Co-Founder and Chief Operations Officer of Medicalchain
Internet entrepreneur and founder of several technology and e-commerce start-ups. Mohammed specialises in bringing together technological efficiencies to the business world. Most recent start-up is ReadyCache, a web acceleration platform using Multi-CDN technology. Mohammed holds an Executive MBA from University of Oxford and a BSc in eCommerce from Brunel University, London.
Follow Mohammed Tayeb:
About Dynistics, Medicalchain: Medicalchain is a decentralized platform that enables secure, fast and transparent exchange and usage of medical data.
Abdullah Albeyatti
CEO & Co-Founder of Medicalchain
Dr Albeyatti graduated from Imperial College London as a doctor in 2011. He has always had a passion for innovation and problem solving and has developed solutions to inefficiencies he found whilst working in the UK National Health Service. In 2016 he co-founded Medicalchain, initially as Discharge Summary – an application used in hospitals to generate accurate medical reports on patients, before they are discharged. Dr Albeyatti’s career in medicine started with surgical training in London and has moved on to general practice with a view to continuing his ENT passion and furthering his management aspirations. He continues to work in Accident and Emergency to sharpen his clinical skill set.
Follow Abdullah Albeyatti:
About dischargesummary.co.uk, Medicalchain, MyClinic, NHS, NHS England: Medicalchain is a decentralized platform that enables secure, fast and transparent exchange and usage of medical data.
Aron Rachamim
Founder & CEO of Senzo
Aron Rachamim is committed to changing the world by putting healthcare information into everyone’s hands. A serial entrepreneur, scientist, and experienced leader, Aron aims to apply pioneering technologies to improve people’s quality of life. His expertise and passion for the science of microfluidics builds on his background in life sciences, physics, and engineering. His company Orphidia intends to transform the world of medical diagnostics. Aron launched Orphidia in 2013 to provide affordable, point-of-care diagnostics that allow everyone to know their health. Orphidia has advanced the state-of-the-art with microfluidic-based medical diagnostics that are minimally invasive, replacing venous blood draws from a phlebotomist with a simple fingerstick that anyone can perform. Aron is a serial entrepreneur, whose background combines a PhD from the University of Cambridge and a focus on microfluidics and biotechnology with strong experience in professional management. At Protein Logic, a spin-out from Cambridge University that raised more than £3 million in initial funding to develop proprietary biomarker technology for the diagnosis and prediction of diseases, he served as COO. At WiseMed, where he was Co-founder, his team developed crowdsourced medical diagnostic technology as an affordable solution for improving healthcare in the developing world. Now, at Orphidia, Aron is providing the vision and leadership that will usher in the next generation of medical diagnostics, empowering everyone to know their health.
Follow Aron Rachamim:
About Senzo: Senzo is a deep-tech bio-med company developing testing products and IP.
Melinda Nicci
Founder and CEO of Baby2Body
Melinda is founder and CEO of Body Collective (Baby2body) the award- winning, wellness company for women.
She is a Sports and Exercise Psychologist, author of two bestselling books, is a regular contributor on the BBC, and sits on numerous boards as a NED, including The ICE List and Team GB (Olympic and Para-olympics snow-sport teams).
Melinda was named the UKBAA High Growth Founder of the year 2019/20, and has won numerous accolades and awards for entrepreneurship, including being named in the UK list of the Most Influential Women in Tech for 4 years running.
A serial entrepreneur, she founded and sold her first business at the age of 25 in South Africa, and held the position of Senior Director for Consumer health Innovation at Philips in Amsterdam. Melinda brings her passion for sport, performance and wellness to the numerous companies she advises and has created a global business with Body Collective, helping millions of women all over the world to live healthier and happier lives.
Follow Melinda Nicci:
About Baby2Body, GB Snowsport, ICE List: Baby2Body is a fully automated health, fitness and wellbeing coaching platform for pregnant women and mothers.
Andrew Dillon
Founder & Chief Executive of National Institute for Health and Care Excellence (NICE)
Andrew Dillon joined the NHS in 1975 and has held a number of senior management positions, including General Manager of the Royal Free Hospital and Chief Executive of St George’s Healthcare NHS Trust. He joined the National Institute for Health and Care Excellence as its founding Chief Executive in 1999.
Follow Andrew Dillon:
About National Institute for Health and Care Excellence (NICE): The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care.
Georgina Kirby
Co-Founder and CTO of Vinehealth
Georgina is a data scientist who has spent her career developing AI-driven health technology. She holds a Master’s in Medical Robotics from Imperial College London and led GSK’s first data-driven clinical trial using remote monitoring to predict patient outcomes at McLaren Applied Technologies. As Head of Data Science and part of the Executive Team at Touch Surgery she built, grew and managed technical teams to deliver data-driven products.
Follow Georgina Kirby:
About Vinehealth: Vinehealth is a AI-driven platform providing support to improve the quality of life and survival of cancer patients.
Rayna Patel
Co-Founder and CEO of Vinehealth
Rayna is a medical doctor and neuroscientist with over a decade of experience in healthcare, working in frontline hospitals, national government policy and clinical research (Cambridge, UCL, Harvard, MIT and Columbia). She held strategic and commercial roles in tech startups, government policy and the Cabinet Office’s Nudge Unit, where she used behavioural neuropsychology to change patient behaviours through commercial products.
Follow Rayna Patel:
About Vinehealth: Vinehealth is a AI-driven platform providing support to improve the quality of life and survival of cancer patients.
Laurence Bargery
Co Founder & CTO of AccuRx
Laurence Bargery is a Co-founder & CTO at accuRx.
Follow Laurence Bargery:
About AccuRx: AccuRx is on a mission to bring patients and their healthcare teams together.
Jacob Haddad
Co-Founder of AccuRx
Jacob Haddad is a Co-Founder at accuRx Company.
Follow Jacob Haddad:
About AccuRx, Entrepreneur First, Founders of the Future: AccuRx is on a mission to bring patients and their healthcare teams together.
Khoa Phan
CEO & Co-Founder of Backbone Labs, Inc.
Khoa’s entrepreneurial spirit and engineering experience drives the strategic vision of Backbone Labs, as well as the development of its products. Before he launched Backbone Labs, Khoa founded a successful marketing agency specializing in search, content and social media ad campaigns for acquiring customers and users. He has also co-founded an indie mobile game studio. When he’s not building companies, Khoa is an avid collector of rare sneakers.
Follow Khoa Phan:
About Backbone Labs, Inc.: Identify at-risk behavior in the workplace and recommend actions to promote and maintain overall back-related wellness.
John E. Milad
CEO & Founder of Quanta
John E. Milad is a global healthcare executive, board member, investor, speaker and author. He has a career spanning over 25 years, with experience working in various senior positions in the healthcare sector, including NBGI Ventures, Atlas Venture, Nitec Pharma and Nomura. Currently, John is Chief Executive Officer and founding board member at Quanta Dialysis Technologies, where he recently raised $245m in Series D funding. An executive with international experience in building and growing successful healthcare companies, John had the vision and belief that core technology of managing fluidics on a disposable cartridge could be developed into a portable hemodialysis device with the potential to address multiple unmet needs in the $93 billion global dialysis market. John is a regular speaker and panelist at global medtech and investment conferences and has co-authored 4 peer-reviewed papers.
Follow John E. Milad:
About NBGI Ventures, Quanta: Quanta develops an advanced haemodialysis systems for use in the home and clinic.
Abdullah Sabyah
Founder and CEO of Rightangled
A scientist-entrepreneur and a healthcare professional, also a member of the British Heart Foundation Alliance, a member of the Clinical Pharmacogenomics Implementation Consortium in the US, and the inventor of a patent pending-technology for nucleic acid testing on a lateral flow assay (the patent is for a technology to detect DNA sequences in real-time).
Follow Abdullah Sabyah:
About Rightangled: Medtech specialised in Genetics, Blood and infection testing. Service is delivers through a platform that connects users with specialists.
Ali Rezaei Haddad
CEO and Founder of NeuroNav
Ali is a neurosurgical resident in London and an NHS Clinical Entrepreneur. Prior to this, he completed his Academic Foundation Training in the Medical Sciences Division at the University of Oxford undertaking research in the field of neuroimaging. He graduated with first class honours in Neurosciences BSc at Imperial College London, and he holds honorary research positions at the University of Oxford and St George’s Medical School. Ali co-founded the internationally acclaimed GoodSAM app used by the NHS, in which clinically trained individuals sign up as volunteers to respond to life-threatening emergency calls. He also directed and curated the Imagining the Future of Medicine at the Royal Albert Hall in partnership with TEDMED, attended by a live audience of 5,000 people. Inspired by the lack of user friendly and affordable neuronavigation solutions worldwide, he founded NeuroNav to democratise access to neurosurgery navigation solutions.
Follow Ali Rezaei Haddad:
About Imperial College Healthcare NHS Trust, NeuroNav: An augmented reality neuronavigation platform powered by computer vision and machine learning.
Ry Morgan
Co-Founder, COO & Product Strategy of Unmind
• Entrepreneurial rapscallion with a background highly attuned to tech, product and enterprise. Founded, built and grown several successful (and less successful!) ventures to-date. x
Follow Ry Morgan:
About Unmind, Yomp: Unmind is a B2B mental health platform providing clinically-backed tools and training.
Nick Taylor
Co-Founder and CEO of Unmind
Follow Nick Taylor:
About Unmind: Unmind is a B2B mental health platform providing clinically-backed tools and training.
Steve Peralta
Co-Founder & Chief Content Officer of Unmind
As a wellbeing consultant and facilitator, Steve has spent the past ten years helping people and organisations take proactive, effective steps to improve their wellbeing and performance. He has supported brands such as BBraun, Barclays, Absa, First National Bank and Discovery Health, focusing on evidence-based, positive behaviour change solutions. Steve designed and led the wellbeing programme for BSG, a South African business and tech consultancy which won the ‘Healthiest Company’ and ‘Healthiest Employees’ titles for small companies in the Discovery Healthy Company Index. Steve co-founded Unmind in 2016 and now works with leading academics and clinicians in creating engaging, evidence-based tools and training to help people understand and proactively support their mental health.
Follow Steve Peralta:
About Unmind: Unmind is a B2B mental health platform providing clinically-backed tools and training.
Nick von Christierson
CEO & Co-Founder of Woven Science
Nick von Christierson is the CEO and Co-Founder at Woven Science.
Follow Nick von Christierson:
About Baby Bundle, Woven Science: Woven Science backs and builds best-in-class companies in the mental wellness space with a focus on psychedelic therapeutics.
Seyed-Mahdi Khaligh-Razavi
Co-Founder and Chief Science Officer of Cognetivity Neurosciences
Seyed-Mahdi Khaligh-Razavi is the Co-Founder and Chief Science Officer at Cognetivity Neurosciences.
Follow Seyed-Mahdi Khaligh-Razavi:
About Cognetivity Neurosciences: Cognetivity Neurosciences is a Platform technology for early, rapid and easy detection of dementia.
Mario Alberto Accardi
CEO and Co-Founder of Orexia
Life sciences executive and investor focused on starting, funding and running companies in the life sciences. Over a decade experience in the industry spanning fundamental research, venture capital and operational roles. I am now CEO and Co-Founder of Orexia and Inexia, two biotech companies founded with VC investor Medicxi and Sosei Heptares. I am also CEO and Co-Founder and inventor behind Orthonika, a medtech spin-out from Imperial College London.
Follow Mario Alberto Accardi:
About Orexia, Orthonika: Orexia aims to develop orally administered orexin positive modulators for the treatment of neurological diseases.
Carina Cunha
Co-Founder & CEO of Be Nosy
Carina is a business strategist and inventor of Nosy with passion for science, sales and marketing. In her former role as MD and Launcher of Crimson Education Europe, she created sales, marketing and service delivery teams from scratch, achieving millions in ARR and 150%+ YoY growth. Prior to working with startups Carina was corporate strategist at JPMorgan, Strategy Consultant at Accenture, Investment Banker at Credit Suisse, and a fashion model with Elite. Carina is also an innovation and commercial consultant through Meta Strategy and Founders Intelligence where she helps startups and scale-ups find product-market fit and corporates build new revenue lines. She has a B.A. from Columbia University and PgD. from the University of Edinburgh.
Follow Carina Cunha:
About Be Nosy: Nosy is a MedTech startup developing wearable air filter and air pollution tracking network.
Thorsten Hagemann
Co-Founder of AliveBiome Ltd
Thorsten Hagemann is an accomplished medical professional and entrepreneur with over 17 years of experience within the healthcare industry. An innovative, investigative forward thinker, Hagemann is passionate about identifying and creating new opportunities that aim to improve general health and prevent illnesses. Hagemann is the Founder of MedAdvise Ltd., a consultancy company focused on the education of the general public and prevention of illness through functional medicine. With an understanding that very few of doctors contribute to preventative medicine, Hagemann was motivated to learn more about the prevention of illness and use this information to educate others so they can live more prosperous lives. Through a deep understanding of the microbiome, Thorsten Hagemann has become a leading research expert and advocate for the health of this community of bacteria living inside our bodies. Not only does he find the subject fascinating, Thorsten understands the importance of treating it just like any other major medical area of study as it has an enormous impact on the health of our bodies. Thorsten is also an advocate for education when it comes to the microbiome, having a passion for showing people how keeping your microbiome healthy can increase overall health and wellness. Through his research, Thorsten Hagemann has found that having an unbalanced microbiome can lead to insomnia, anxiety, depression, loss of focus, obesity, diabetes, and even cancer. With preventive care and a balanced microbiome, the human body can experience better digestion, a drop in mood swings, and a healthier immune system. Hagemann hopes to teach as many people as possible about the benefits of a balanced microbiome through his work and research. Thorsten Hagemann was also recently given the opportunity to co-found another company surrounding microbiome research, called AliveBiome. This company’s focus is to give people direct access to nutrients and supplements that can improve the health of their microbiome. By taking care of the microbiome and supplementing it with the proper diet and exercise, AliveBiome and Thorsten Hagemann believe that one’s health can dramatically improve and even prevent further disease and illness. Thorsten Hagemann is also an avid cyclist. Seeing the happiness that the sport brought to other members of his family, Thorsten began biking himself. He has trained for several major cycling events, including the Paris-Roubaix in Northern France; one of the world’s oldest cycling races. The combination of a full body work-out, the joy of riding, and the chance to see the world has kept Thorsten attached to the sport.
Follow Thorsten Hagemann:
About AliveBiome Ltd, MedAdvise Ltd.: Food as Medicine
Brian Crowther
Co-Founder of AliveBiome Ltd
Brian Crowther is the Co-Founder at AliveBiome Ltd.
Follow Brian Crowther:
About AliveBiome Ltd: Food as Medicine
Charles Wells
Founder & CEO of HelloSelf
Follow Charles Wells:
About Braintech, HelloSelf: HelloSelf is a health and wellness platform that provides its users with digital access to therapists.
Sophie Dundovic
Co-Founder of Parasym
Sophie Dundovic is a Co-founder at Parasym.
Follow Sophie Dundovic:
About Parasym: Parasym is a neurotechnology company focused on providing innovative neurostimulation products that improve quality of life.
Andrea Spezzi
Chief Medical Officer & Co-Founder of Orchard Therapeutics
Andrea is a co-founder of Orchard Therapeutics and brings to the company extensive experience and expertise in the development and execution of all aspects of clinical development and particularly in paediatric rare diseases. Prior to joining Orchard Therapeutics, Andrea served as VP and Medicine Development Leader at GSK Rare Diseases Unit. Previous to joining the GSK Rare Diseases Unit, Andrea was Senior Medical Director at the Immune Inflammation Discovery Performance Unit. Before GSK, Andrea was Global Medical Director R&D at Takeda in the metabolic and cardiovascular area and in charge of the paediatric developments for Takeda Europe R&D. Before that, she worked as Research Physician at Hammersmith Medicines Research. Before moving to the pharmaceutical industry Andrea practiced as a paediatrician for 12 years in Argentina, Spain and UK. Andrea obtained her medical degree from the University of Buenos Aires (UBA) and completed residency in paediatrics and post graduate training in paediatric immunology at the Dr Elizalde Children’s Hospital in Buenos Aires, Argentina. She obtained a Specialist in Pharmaceutical Medicine degree from University of Basel, Switzerland and she is a Fellow of the Faculty of Pharmaceutical Medicine in London, UK (FFPM).
Follow Andrea Spezzi:
About Orchard Therapeutics: Orchard Therapeutics is a biotechnology company dedicated to transforming the lives of patients through innovative gene therapies.
Ali Parsa
Founder and CEO of Babylon
Ali is an entrepreneur and engineer. He built Circle to become Europe’s largest partnership of clinicians, achieving around £200M in annual revenue, 3000 employees and a successful IPO, all during an economic recession. He was named by The Times as among the 100 global people to watch, and was the recipient of the Royal Award for young entrepreneurs for founding V&G earlier in his career. Ali is a UK Cabinet Office Ambassador and has a PhD in engineering Physics.
Follow Ali Parsa:
About Babylon: Babylon is a world leading, digital-first, value-based care company.
Zhangming Niu
Founder & CEO of MindRank AI
Follow Zhangming Niu:
About MindRank AI: MindRank is a developer of an AI-enabled drug-discovery platform intended to discover and develop next generation precision medicines.
James Noble
Founder & CEO of Adaptimmune
James Noble has served as our full-time Chief Executive Officer since March 2014 and part-time CEO from July 2008 to March 2014 and is one of our co-founders. From July 2008 until March 2014, Mr. Noble was also part-time CEO of Immunocore. Mr. Noble has 24 years of experience in the biotech industry. He has held numerous non-executive director positions, including at CuraGen Corporation, PowderJect Pharmaceuticals plc, Oxford GlycoSciences plc, MediGene AG, and Advanced Medical Solutions plc. Mr. Noble is also Deputy Chairman of GW Pharmaceuticals plc and a non-executive director of Immunocore Limited. Mr. Noble is qualified as a chartered accountant with Pricewaterhouse Coopers and spent seven years at the investment bank Kleinwort Benson Limited, where he became a director in 1990. He then joined British Biotech plc as Chief Financial Officer from 1990 to 1997. Mr. Noble was previously Chief Executive Officer of Avidex Limited, a privately held biotechnology company that was our predecessor, from 2000 to 2006. Mr. Noble holds an MA from the University of Oxford.
Follow James Noble:
About Adaptimmune, Advanced Medical Solutions, Curagen Corporation, MediGene, Oxford GlycoSciences, PowderJect Pharmaceuticals: Adaptimmune develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.
Ian Mills
Director of Software Engineering and Co-Founder of Clinpal
Ian has been directly involved in the development of some of the leading, and most advanced EDC systems brought to market in the last 15 years. At eClinicalHealth, he continues to lead from the front by supporting clients integrate and extend their eClinical solutions. Ian is an expert in agile software development methods, and besides his hands-on technical prowess he has take the lead in ensuring organizations he works with have bullet proof auditability throughout their product development lifecycle. All work carried out at eClinicalHealth follows either our own rigorous agile Software Development LifeCycle, or, if preferred our sponsors. Ian’s EDC products have been used globally by companies such as Roche, Novartis, Merck and Johnson & Johnson. Ian is a master of CDISC standards – ODM specifically – as well as Web technologies for regulated industries that include; RUP, XP, UML, SCRUM, Agile Development, JEE (JPA, JSF, JSP, JMS, JMX, JTA), Spring Framework, Eclipse, Hibernate, Tapestry, Web Services, JavaScript, Ajax, GWT, JQuery, SQL (Oracle, DB2, MySQL), XML, NoSQL Databases (ObjectStore, Mongo, CouchDB), C/C++, Groovy, Python. Besides Ian’s computing language proficiency, Ian is also fluent in both English and German.
Follow Ian Mills:
About Clinpal: Clinpal is a leading cloud-based digital patient recruitment and engagement platform.
Soumyadip Rakshit
Co-Founder & CEO of MysteryVibe
Soumyadip is a serial entrepreneur and Co-Founder of sex-tech company MysteryVibe . His mission is to apply Intelligence of Things to the world of Pleasure and create and immersive experience to transform bedrooms into sensual sanctuaries. The mission is gaining pace. MysteryVibe won the consumer product design category at the Design Week awards, beating the Apple Watch. Last year, it closed a funding round worth $1.5 million (£1.1 million) bringing the total raised by the company to over $4 million in three years and valuing it at $13 million. The sex-tech market, which is estimated to be worth $15 billion, has so far had very little outside investment. Rakshit says: “There’s huge potential, and that’s helped investors get over their initial reservations about the sector.” He still loves the moment at tech conferences when he starts talking about sex and pleasure and people’s expressions turn from smiles and giggles to curiosity and seriousness.
Follow Soumyadip Rakshit:
About MysteryVibe: Award Winning Sexual Health Products. Deeply researched, anatomically designed, doctor-endorsed products to make intimacy easy.
Robert Weekly
Co-Founder & CTO of MysteryVibe
Robert Weekly Co-Founder & CTO at MysteryVibe.
Follow Robert Weekly:
About MysteryVibe: Award Winning Sexual Health Products. Deeply researched, anatomically designed, doctor-endorsed products to make intimacy easy.
Hamish Grierson
CEO & Co-Founder of Thriva
Hamish Grierson is the CEO and co-founder of Thriva.
Follow Hamish Grierson:
About Thriva: Thriva offers a personalized at-home finger-prick blood test which enables individuals to easily track and improve health.
Tom Livesey
Co-Founder & CTO of Thriva
Tom Livesey is the CTO and co-founder of Thriva. Prior to co-founding Thriva, Tom served as a contract software engineer at Newspaper Club and as a CTO at Droplet Online Limited.
Follow Tom Livesey:
About Thriva: Thriva offers a personalized at-home finger-prick blood test which enables individuals to easily track and improve health.
Eliot Brooks
Co-Founder & COO of Thriva
Eliot Brooks is Co-founder and COO at Thriva. Prior to this, he perforemed various roles at Tandem Bank and was once a manager at Travelex. He bears a degree in economics from University of Oxford.
Follow Eliot Brooks:
About Thriva: Thriva offers a personalized at-home finger-prick blood test which enables individuals to easily track and improve health.
Tamara Rajah
Founder & CEO of Live Better With
A couple of years ago, Tamara got really frustrated from her professional and personal experiences. She found that there are so many things that could help people living with cancer live better day-to-day, but they don’t know about them or don’t know where to buy them. She left her job in healthcare and set up Live Better With to change that.
Follow Tamara Rajah:
About Live Better With: Make life a little bit better with 100s of recommended products for people living with cancer.
Kaveh Memari
Founder of AYR
As the Founder and first CEO of AYR, and in working in partnership with Ian and Adrian, Kaveh has been responsible for the creation of AYR from the start. Over the past 17 years, Kaveh has acted as Founder and CEO in start-ups responsible for inventing new technologies and forming these into consumer products that address fundamental health and environmental challenges. He has been responsible for creating and driving the vision, assembling the teams to execute, and raising the necessary capital to bring these projects to life. Over 160 investors and institutions have backed these projects to date.
Follow Kaveh Memari:
About AYR: AYR is an e-cigarette that provides an alternative to smoking.
Ian Murison
CDO and Co-Founder of AYR
Ian is an award-winning industrial designer whose work in diverse sectors from consumer electronics to fragrance development led to the founding of AYR. Since 2001 Ian has been running Curventa, a London based award-winning Industrial design agency with his business partner and co-founder Adrian Bennett.
Follow Ian Murison:
About AYR: AYR is an e-cigarette that provides an alternative to smoking.
Adrian Bennett
Co-Founder of AYR
Since 2001 Adrian has run Curventa, an industrial design company, helping companies large and small, target their customers and provide them with compelling consumer products and experiences. He has worked for over 25 years building a wealth of experience not just in the field of design, but also in product delivery and manufacture.
Follow Adrian Bennett:
About AYR: AYR is an e-cigarette that provides an alternative to smoking.
Tess Cosad
Co-Founder & CEO of Bea Fertility
Tess Isabelle Cosad is the Chief Executive Officer and Co-Founder of Bea Fertility.
Follow Tess Cosad:
About Bea Fertility: Bea Fertility is a monthly subscription program that provides users with at-home fertility treatment and ovulation tracking.
David O’Rourke
Co-Founder and Chief Scientific Officer (CSO) & Chief Innovation Officer (CIO) of Bea Fertility
David O’Rourke is the Chief Operating Officer and Co-Founder of Bea Fertility.
Follow David O’Rourke:
About Bea Fertility, Vitrolife: Bea Fertility is a monthly subscription program that provides users with at-home fertility treatment and ovulation tracking.
Calvin Benton
Founder & CEO of Spill App
During university, Calvin took time out to learn the equivalent of a computer science degree in just a year, funded by a job-matching site and cake delivery firm he’d founded.
Follow Calvin Benton:
About Spill App: Spill is a startup that offers a message-based therapy app to help improve workplace well-being.
Zubair Ahmed
CEO & Founder of MedicSpot
Follow Zubair Ahmed:
About MedicSpot: MedicSpot gives patients convenient and quick access to healthcare using the latest advancements in telemedicine
Barney Gilbert
Founder, Co-CEO of Pando
Barney Gilbert worked in the NHS as a doctor before founding Pando, a healthtech company working to connect everyone working in healthcare. Listed in the UK’s Disruption50 Index for 2019. Forbes 30 Under 30 alum.
Follow Barney Gilbert:
About NHS England, Pando: Forward is now Pando! Pando is an essential tool for teamwork and secure collaboration in health and social care.
